David Zervos, Jefferies chief market strategist, and Jeffrey Kleintop, Charles Schwab chief global investment strategist, ...

Jefferies’ five-star-rated analyst, Brent Thill, today flagged heavy insider selling in Palantir Technologies’ (PLTR) stock.

Jefferies has initiated Krystal Biotech at buy citing growth in sales of Vyjuvek (beremagene geperpavec), a gene therapy for ...

With Friday's nonfarm payrolls report for February just two days away, Chief U.S. Economist Thomas Simons of Jefferies hasn't changed his view that the data will likely miss expectations. His call for ...

SEA (NYSE:SE – Get Free Report) had its price target boosted by stock analysts at Jefferies Financial Group from $131.00 to ...

China’s smartphone market is experiencing a slowdown, with sales growth momentum stalling despite government subsidies that ...

President Xi Jinping held a rare meeting with some of the biggest names in China’s technology sector, urging them to “show ...

Jefferies reiterated its 'Buy' call on RIL with a target price of Rs 1,600 per share, while Kotak Institutional upgraded the stock to 'Buy', stating that the risk-reward appear favourable now.

Societe Generale SA’s digital retail unit will see a decline in costs and help the French bank achieve higher profitability, ...

Okta (NASDAQ:OKTA – Free Report) had its price objective raised by Jefferies Financial Group from $90.00 to $110.00 in a ...

The Jefferies analyst feels capacity utilization could reach 94% from the current 88%. They note that when utilization was last that high from 2019 to 2020, day rates hit a stunning $95,000 daily.

Shares of Nike advanced about 5%, one of the best performers in the S&P 500 Monday, after Jefferies raised its recommendation ...